Fibulin 2 antibody
GTX105108
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetFBLN2
Overview
- SupplierGeneTex
- Product NameFibulin 2 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.19 mg/ml
- ConjugateUnconjugated
- Gene ID2199
- Target nameFBLN2
- Target descriptionfibulin 2
- Target synonymsfibulin-2, FIBL-2
- HostRabbit
- IsotypeIgG
- Protein IDP98095
- Protein NameFibulin-2
- Scientific DescriptionThis gene encodes an extracellular matrix protein, which belongs to the fibulin family. This protein binds various extracellular ligands and calcium. It may play a role during organ development, in particular, during the differentiation of heart, skeletal and neuronal structures. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Patel MR, Weaver AM. Astrocyte-derived small extracellular vesicles promote synapse formation via fibulin-2-mediated TGF-β signaling. Cell Rep. 2021,34(10):108829. doi: 10.1016/j.celrep.2021.108829Read this paper
- Kanan Y, Brobst D, Han Z, et al. Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem. 2014,289(19):13419-33. doi: 10.1074/jbc.M114.562157Read this paper
- Slany A, Haudek-Prinz V, Meshcheryakova A, et al. Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma. J Proteome Res. 2014,13(2):844-54. doi: 10.1021/pr400881pRead this paper
- Karakikes I, Chaanine AH, Kang S, et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013,2(2):e000078. doi: 10.1161/JAHA.113.000078Read this paper






